BRIEF published on 04/07/2025 at 07:05, 1 year ago Julius Baer Introduces Organizational Changes for Enhanced Client Focus Digital Transformation Wealth Management Julius Baer Organizational Change Client Focus
BRIEF published on 04/07/2025 at 07:05, 1 year ago Julius Baer introduit des changements organisationnels pour une meilleure orientation client Transformation Numérique Julius Baer Gestion De Patrimoine Changement Organisationnel Orientation Client
BRIEF published on 04/07/2025 at 00:10, 1 year ago Sea Pharmaceuticals Partners with Inotiv to Develop CNS Treatments Sea Pharmaceuticals Inotiv Inc. SPM-0404 CNS Disorders Glutamate Pathway
BRIEF published on 04/07/2025 at 00:10, 1 year ago Sea Pharmaceuticals s'associe à Inotiv pour développer des traitements du système nerveux central Sea Pharmaceuticals Inotiv Inc. SPM-0404 Troubles Du Système Nerveux Central Voie Du Glutamate
BRIEF published on 04/06/2025 at 18:25, 1 year ago QIAGEN Reports Strong Q1 2025 Results and Revises EPS Outlook Net Sales Growth EPS Outlook QIAGEN Q1 2025 QuantiFERON Sales QIAstat-Dx Performance
BRIEF published on 04/06/2025 at 18:25, 1 year ago QIAGEN publie de solides résultats pour le premier trimestre 2025 et révise ses perspectives de bénéfice par action Croissance Des Ventes Nettes QIAGEN T1 2025 Perspectives De BPA Ventes De QuantiFERON Performances De QIAstat-Dx
BRIEF published on 04/06/2025 at 15:14, 1 year ago DEUTZ Acquires Electrification Developer UMS Growth Market Strategic Expansion Electrification Solutions DEUTZ Acquisition UMS Technology
BRIEF published on 04/06/2025 at 15:14, 1 year ago DEUTZ acquiert le développeur d'électrification UMS Expansion Stratégique Marché En Croissance Solutions D'électrification Acquisition De DEUTZ Technologie UMS
BRIEF published on 04/05/2025 at 05:55, 1 year ago Lobe Sciences Provides Corporate Update on Recent Transactions Clinical Trials Convertible Notes FDA Feedback Lobe Sciences Psilocin Mucate
BRIEF published on 04/05/2025 at 05:55, 1 year ago Lobe Sciences fournit une mise à jour de l'entreprise sur les transactions récentes Essais Cliniques Billets Convertibles Commentaires De La FDA Sciences Du Lobe Mucate De Psilocine
Published on 04/21/2026 at 22:45, 17 minutes ago Viemed Healthcare Announces First Quarter 2026 Earnings Conference Call Details
Published on 04/21/2026 at 17:40, 5 hours 22 minutes ago Karbon-X Reports $60.8 Million in Nine-Month Revenue and Files Q3 Form 10-Q
Published on 04/21/2026 at 15:00, 8 hours 2 minutes ago Route1 Announces Launch Of "Mr. Parking" And Provides Update On Upcoming Financial Reporting
Published on 04/21/2026 at 22:15, 47 minutes ago Amrize Shareholders Approve All Proposals at 2026 Annual General Meeting
Published on 04/21/2026 at 20:50, 2 hours 12 minutes ago CATL Unveils Six Major Innovations: Multi-Chemistry Systems to Redefine New Energy Mobility Experience
Published on 04/21/2026 at 19:15, 3 hours 47 minutes ago Shelly Group SE publishes 2025 Investors Report as an established transparency format
Published on 04/21/2026 at 19:08, 3 hours 53 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 04/21/2026 at 19:02, 3 hours 59 minutes ago Brockhaus Technologies AG: Actions for annulment and nullity against the approval resolution of the Extraordinary General Meeting of February 26, 2026
Published on 04/21/2026 at 19:15, 3 hours 47 minutes ago AXA - Description of the Company’s share repurchase program
Published on 04/21/2026 at 19:15, 3 hours 47 minutes ago AXA - Descriptif du programme de rachat d’actions
Published on 04/21/2026 at 18:00, 5 hours 2 minutes ago Outstanding shares and voting rights statement at 31 March 2026
Published on 04/21/2026 at 18:00, 5 hours 2 minutes ago Publication du nombre d’actions composant le capital et du nombre total de droits de vote au 31 mars 2026
